In this meta-analysis of randomized controlled trials in participants with chronic kidney disease, alpha-lipoic acid decreased levels of total cholesterol and C-reactive protein, but it did not affect other blood lipid measurements or biomarkers of inflammation and oxidative stress.
This Study Summary was published on November 19, 2024.
